Genenta Science S.p.A.
NASDAQ:GNTA
3.8 (USD) • At close July 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -8.908 | -0.004 | -0.005 | -6.696 | -0.006 | -0.002 | -0.001 | -0.004 | -0.003 | -0.002 | -2.299 | -2.299 |
| Depreciation & Amortization
| 0.045 | 0 | 0 | 0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | -0.042 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.847 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.375 | 0.375 |
| Change In Working Capital
| 1.716 | 0.002 | 0.001 | -1.286 | 0 | -0.001 | -0.001 | -0.001 | -0 | -0.001 | 0.677 | 0.677 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0.032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.014 | -0.014 |
| Other Working Capital
| 1.684 | 0.002 | 0.001 | -1.286 | 0 | -0.001 | -0.001 | -0.001 | -0 | -0.001 | 0.69 | 0.69 |
| Other Non Cash Items
| 0.063 | 0 | 0 | 0.494 | 0.001 | 0 | -0 | -0 | -0.001 | 0.001 | 0.002 | 0.002 |
| Operating Cash Flow
| -6.238 | -0.002 | -0.004 | -7.51 | -0.005 | -0.003 | -0.002 | -0.005 | -0.004 | -0.002 | -1.245 | -1.245 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.004 | -0 | -0 | -0.012 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -16.38 | 0 | 0 | -9.896 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 23.268 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.004 | 0.004 | -0.005 | -0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 6.879 | 0.004 | -0.005 | -9.908 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.543 | 7.543 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.271 | 0 | 0 | 0 | 0 | 0 | 0.029 | -0 | 0.001 | 0 | -0.159 | -0.159 |
| Financing Cash Flow
| 0.271 | 0 | 0 | 0 | 0 | 0 | 0.029 | -0 | 0.001 | 0 | 7.384 | 7.384 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.023 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 4.576 | 0.006 | -0.012 | -17.418 | -0.002 | -0.001 | 0.013 | -0.002 | -0.001 | -0.001 | 12.278 | 12.278 |
| Cash At End Of Period
| 4.582 | 0.006 | 3.694 | 12.216 | -0.002 | 0.035 | 0.037 | 0.011 | 0.015 | 0.018 | 20.141 | 20.141 |